Tag:
MTN Zakhele Futhi
DealMakers
Weekly corporate finance activity by SA exchange-listed companies
Weekly summary of corporate finance activity by South African exchange listed companies
Ghost Bites
Ghost Bites (Assura – Primary Health Properties | Labat Africa | MC Mining | Ninety One | Orion Minerals | Southern Palladium)
Assura's reasons for changing their recommendation on KKR / Stonepeak look weaker by the day. Orion Minerals supports small shareholders. Ninety One's AUM moved higher. Labat Africa might dispose of businesses. MC Mining needs a turnaround at Uitkomst. Southern Palladium gives further details on the optimised prefeasibility study.
DealMakers
Weekly corporate finance activity by SA exchange-listed companies
Weekly summary of corporate finance activity by South African exchange listed companies
Ghost Bites
Ghost Bites (Assura – Primary Health Properties | South32)
Assura shareholders aren't exactly rushing to accept the Primary Health Properties offer, with Primary Health releasing a trading update to try and drive more acceptances. South32 is getting rid of the nickel mine in Colombia.
DealMakers
Weekly corporate finance activity by SA exchange-listed companies
Weekly summary of corporate finance activity by South African exchange listed companies
Ghost Bites
Ghost Bites (AH-Vest | Assura – Primary Health | Goldrush | Harmony | Naspers – Prosus)
The excellent momentum at Naspers - Prosus continues. Assura is now backing the Primary Health deal in yet another example of corporate whiplash. Harmony is delivering at the right time. Goldrush released a trading statement. AH-Vest is being taken private.
DealMakers
Weekly corporate finance activity by SA exchange-listed companies
Weekly summary of corporate finance activity by South African exchange listed companies
Ghost Bites
Ghost Bites (Gemfields | Merafe | MTN Zakhele Futhi | Novus | Primary Health Properties – Assura | Remgro – Mediclinic | Vunani)
Primary Health is making another desperate plea to Assura. MTN Zakhele Futhi is cashing in. Novus is up, but on shaky ground. Gemfields enjoyed decent support for the rights offer. Look out for Merafe, Mediclinic (Remgro) and Vunani as well.
